Vandana Singh
·
March 7, 2025
Benzinga
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
read more
April 30, 2025
March 31, 2025
Financial Times
March 13, 2025
March 20, 2025